Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

0
Player Avatar IBDvalueinvestin (99.49) Submitted: 1/31/2012 11:57:00 AM : Outperform Start Price: $35.96 VRTX Score: +7.37

VRTX wins FDA approval again..

Report this Post Reply

Featured Broker Partners


Advertisement